112 related articles for article (PubMed ID: 22510381)
1. Nephrological abnormalities in patients with transaldolase deficiency.
Loeffen YG; Biebuyck N; Wamelink MM; Jakobs C; Mulder MF; Tylki-Szymańska A; Fung CW; Valayannopoulos V; Bökenkamp A
Nephrol Dial Transplant; 2012 Aug; 27(8):3224-7. PubMed ID: 22510381
[TBL] [Abstract][Full Text] [Related]
2. [Transaldolase deficiency - clinical outcome, pathogenesis, diagnostic process].
Lipiński P; Stradomska T; Tylki-Szymańska A
Dev Period Med; 2018; 22(2):187-196. PubMed ID: 30056406
[TBL] [Abstract][Full Text] [Related]
3. Untargeted metabolomics as an unbiased approach to the diagnosis of inborn errors of metabolism of the non-oxidative branch of the pentose phosphate pathway.
Shayota BJ; Donti TR; Xiao J; Gijavanekar C; Kennedy AD; Hubert L; Rodan L; Vanderpluym C; Nowak C; Bjornsson HT; Ganetzky R; Berry GT; Pappan KL; Sutton VR; Sun Q; Elsea SH
Mol Genet Metab; 2020; 131(1-2):147-154. PubMed ID: 32828637
[TBL] [Abstract][Full Text] [Related]
4. Transaldolase deficiency caused by the homozygous p.R192C mutation of the TALDO1 gene in four Emirati patients with considerable phenotypic variability.
Al-Shamsi AM; Ben-Salem S; Hertecant J; Al-Jasmi F
Eur J Pediatr; 2015 May; 174(5):661-8. PubMed ID: 25388407
[TBL] [Abstract][Full Text] [Related]
5. Detection of transaldolase deficiency by quantification of novel seven-carbon chain carbohydrate biomarkers in urine.
Wamelink MM; Smith DE; Jansen EE; Verhoeven NM; Struys EA; Jakobs C
J Inherit Metab Dis; 2007 Oct; 30(5):735-42. PubMed ID: 17603756
[TBL] [Abstract][Full Text] [Related]
6. Clinical, biochemical, and molecular overview of transaldolase deficiency and evaluation of the endocrine function: Update of 34 patients.
Williams M; Valayannopoulos V; Altassan R; Chung WK; Heijboer AC; Keng WT; Lapatto R; McClean P; Mulder MF; Tylki-Szymańska A; Walenkamp ME; Alfadhel M; Alakeel H; Salomons GS; Eyaid W; Wamelink MMC
J Inherit Metab Dis; 2019 Jan; 42(1):147-158. PubMed ID: 30740741
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular characteristics of two transaldolase-deficient patients.
Tylki-Szymanska A; Wamelink MM; Stradomska TJ; Salomons GS; Taybert J; Dąbrowska-Leonik N; Rurarz M
Eur J Pediatr; 2014 Dec; 173(12):1679-82. PubMed ID: 24497183
[TBL] [Abstract][Full Text] [Related]
8. Transaldolase deficiency in a two-year-old boy with cirrhosis.
Wamelink MM; Struys EA; Salomons GS; Fowler D; Jakobs C; Clayton PT
Mol Genet Metab; 2008 Jun; 94(2):255-8. PubMed ID: 18331807
[TBL] [Abstract][Full Text] [Related]
9. Transaldolase deficiency: report of 12 new cases and further delineation of the phenotype.
Eyaid W; Al Harbi T; Anazi S; Wamelink MM; Jakobs C; Al Salammah M; Al Balwi M; Alfadhel M; Alkuraya FS
J Inherit Metab Dis; 2013 Nov; 36(6):997-1004. PubMed ID: 23315216
[TBL] [Abstract][Full Text] [Related]
10. Transaldolase deficiency in two new patients with a relative mild phenotype.
Tylki-Szymańska A; Stradomska TJ; Wamelink MM; Salomons GS; Taybert J; Pawłowska J; Jakobs C
Mol Genet Metab; 2009 May; 97(1):15-7. PubMed ID: 19299175
[TBL] [Abstract][Full Text] [Related]
11. Hypergonadotrophic hypogonadism in a patient with transaldolase deficiency: novel mutation in the pentose phosphate pathway.
Lafcı NG; Colak FK; Sahin G; Sakar M; Çetinkaya S; Savas-Erdeve S
Hormones (Athens); 2021 Sep; 20(3):581-585. PubMed ID: 33159679
[TBL] [Abstract][Full Text] [Related]
12. Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway.
Verhoeven NM; Huck JH; Roos B; Struys EA; Salomons GS; Douwes AC; van der Knaap MS; Jakobs C
Am J Hum Genet; 2001 May; 68(5):1086-92. PubMed ID: 11283793
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of pentose phosphate pathway-associated polyols in early postnatal life.
Koy A; Waldhaus A; Hammen HW; Wendel U; Mayatepek E; Schadewaldt P
Neonatology; 2009; 95(3):256-61. PubMed ID: 18987485
[TBL] [Abstract][Full Text] [Related]
14. Novel heterozygous mutations in TALDO1 gene causing transaldolase deficiency and early infantile liver failure.
Balasubramaniam S; Wamelink MM; Ngu LH; Talib A; Salomons GS; Jakobs C; Keng WT
J Pediatr Gastroenterol Nutr; 2011 Jan; 52(1):113-6. PubMed ID: 21119539
[No Abstract] [Full Text] [Related]
15. Transaldolase deficiency: a new cause of hydrops fetalis and neonatal multi-organ disease.
Valayannopoulos V; Verhoeven NM; Mention K; Salomons GS; Sommelet D; Gonzales M; Touati G; de Lonlay P; Jakobs C; Saudubray JM
J Pediatr; 2006 Nov; 149(5):713-7. PubMed ID: 17095351
[TBL] [Abstract][Full Text] [Related]
16. Profiling of pentose phosphate pathway intermediates in blood spots by tandem mass spectrometry: application to transaldolase deficiency.
Huck JH; Struys EA; Verhoeven NM; Jakobs C; van der Knaap MS
Clin Chem; 2003 Aug; 49(8):1375-80. PubMed ID: 12881455
[TBL] [Abstract][Full Text] [Related]
17. A newborn with severe liver failure, cardiomyopathy and transaldolase deficiency.
Verhoeven NM; Wallot M; Huck JH; Dirsch O; Ballauf A; Neudorf U; Salomons GS; van der Knaap MS; Voit T; Jakobs C
J Inherit Metab Dis; 2005; 28(2):169-79. PubMed ID: 15877206
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentations of patients with polyol abnormalities.
Huck JH; Verhoeven NM; van Hagen JM; Jakobs C; van der Knaap MS
Neuropediatrics; 2004 Jun; 35(3):167-73. PubMed ID: 15248099
[TBL] [Abstract][Full Text] [Related]
19. The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review.
Wamelink MM; Struys EA; Jakobs C
J Inherit Metab Dis; 2008 Dec; 31(6):703-17. PubMed ID: 18987987
[TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function.
Charnas LR; Bernardini I; Rader D; Hoeg JM; Gahl WA
N Engl J Med; 1991 May; 324(19):1318-25. PubMed ID: 2017228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
